Vir Biotechnology, Inc. (VIR) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $26.0K | -96.9% |
| 2024 | $845.0K | -69.4% |
| 2023 | $2.77M | -98.1% |
| 2022 | $146.32M | +122.1% |
| 2021 | $65.86M | — |
| 2020 | $0 | — |
| 2019 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $26.0K | -96.9% |
| 2024 | $845.0K | -69.4% |
| 2023 | $2.77M | -98.1% |
| 2022 | $146.32M | +122.1% |
| 2021 | $65.86M | — |
| 2020 | $0 | — |
| 2019 | $0 | — |